225 related articles for article (PubMed ID: 27308648)
1. Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP).
Papapostoli I; Lammert F; Stokes CS
J Gastrointestin Liver Dis; 2016 Jun; 25(2):175-81. PubMed ID: 27308648
[TBL] [Abstract][Full Text] [Related]
2. Steatosis regression assessed by cap after Vitamin 'D' supplementation in NAFLD patients with Vitamin 'D' deficiency.
Emam RF; Soliman AF; Darweesh SK; AbdElmagid RA; Ibrahim OM; Mohamed DM
Eur J Gastroenterol Hepatol; 2024 Jan; 36(1):101-106. PubMed ID: 37942743
[TBL] [Abstract][Full Text] [Related]
3. Effects of Gene Variants Controlling Vitamin D Metabolism and Serum Levels on Hepatic Steatosis.
Jamka M; Arslanow A; Bohner A; Krawczyk M; Weber SN; Grünhage F; Lammert F; Stokes CS
Digestion; 2018; 97(4):298-308. PubMed ID: 29514138
[TBL] [Abstract][Full Text] [Related]
4. Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.
Dasarathy J; Varghese R; Feldman A; Khiyami A; McCullough AJ; Dasarathy S
J Nutr; 2017 Oct; 147(10):1938-1946. PubMed ID: 28814531
[No Abstract] [Full Text] [Related]
5. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
[TBL] [Abstract][Full Text] [Related]
6. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
[TBL] [Abstract][Full Text] [Related]
7. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial.
Lukenda Zanko V; Domislovic V; Trkulja V; Krznaric-Zrnic I; Turk-Wensveen T; Krznaric Z; Filipec Kanizaj T; Radic-Kristo D; Bilic-Zulle L; Orlic L; Dinjar-Kujundzic P; Poropat G; Stimac D; Hauser G; Mikolasevic I
Diabetes Obes Metab; 2020 Nov; 22(11):2097-2106. PubMed ID: 32613718
[TBL] [Abstract][Full Text] [Related]
10. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Chan WK; Nik Mustapha NR; Mahadeva S
J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
[TBL] [Abstract][Full Text] [Related]
11. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
12. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
[TBL] [Abstract][Full Text] [Related]
13. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.
de Lédinghen V; Vergniol J; Capdepont M; Chermak F; Hiriart JB; Cassinotto C; Merrouche W; Foucher J; Brigitte le B
J Hepatol; 2014 May; 60(5):1026-31. PubMed ID: 24378529
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency in non-alcoholic fatty liver disease: The chicken or the egg?
Lee SM; Jun DW; Cho YK; Jang KS
Clin Nutr; 2017 Feb; 36(1):191-197. PubMed ID: 26615912
[TBL] [Abstract][Full Text] [Related]
15. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
Trials; 2014 Nov; 15():430. PubMed ID: 25376735
[TBL] [Abstract][Full Text] [Related]
16. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity.
Black LJ; Jacoby P; She Ping-Delfos WC; Mori TA; Beilin LJ; Olynyk JK; Ayonrinde OT; Huang RC; Holt PG; Hart PH; Oddy WH; Adams LA
J Gastroenterol Hepatol; 2014 Jun; 29(6):1215-22. PubMed ID: 24611991
[TBL] [Abstract][Full Text] [Related]
17. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases.
Stokes CS; Volmer DA
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1311-1317. PubMed ID: 27863206
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D Supplementation Improves Quality of Life and Physical Performance in Osteoarthritis Patients.
Manoy P; Yuktanandana P; Tanavalee A; Anomasiri W; Ngarmukos S; Tanpowpong T; Honsawek S
Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933742
[TBL] [Abstract][Full Text] [Related]
19. The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial.
Luger M; Kruschitz R; Marculescu R; Haslacher H; Hoppichler F; Kallay E; Kienbacher C; Klammer C; Kral M; Langer F; Luger E; Prager G; Trauner M; Traussnigg S; Würger T; Schindler K; Ludvik B
Trials; 2015 Aug; 16():328. PubMed ID: 26242295
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Pu K; Wang Y; Bai S; Wei H; Zhou Y; Fan J; Qiao L
BMC Gastroenterol; 2019 Apr; 19(1):51. PubMed ID: 30961539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
